BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31586666)

  • 1. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
    Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
    Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
    J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
    Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
    Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis.
    Upadhyay R; Ayan AS; Jain S; Klamer BG; Perlow HK; Zoller W; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Raval RR; Palmer JD
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):275-284. PubMed ID: 37574170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
    Donovan EK; Parpia S; Greenspoon JN
    Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
    Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
    Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
    J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastases.
    Zhang Q; Hamilton D; Conway P; Xie SJ; Haghighi N; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):308-319. PubMed ID: 36847751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
    Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
    Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.
    Weingarten N; Kruser TJ; Bloch O
    Clin Neurol Neurosurg; 2019 Apr; 179():14-18. PubMed ID: 30784894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.
    Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
    Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.
    Ohtakara K; Hayashi S; Nakayama N; Ohe N; Yano H; Iwama T; Hoshi H
    J Neurooncol; 2012 May; 108(1):201-9. PubMed ID: 22392126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative stereotactic radiosurgery for patients with resected brain metastases: a volumetric analysis.
    Patel RA; Lock D; Helenowski IB; Chandler JP; Tate MC; Bloch O; Sachdev S; Kruser TJ
    J Neurooncol; 2018 Nov; 140(2):395-401. PubMed ID: 30084023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.